Shuttle Pharmaceuticals Holdings Inc (SHPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,722 | -9,107 | -6,760 | -3,053 | -9,145 |
| Depreciation Amortization | 352 | 49 | 30 | 8 | 1,085 |
| Other Working Capital | 541 | -8 | 460 | -77 | 139 |
| Other Operating Activity | 1,347 | 557 | 388 | 596 | 594 |
| Operating Cash Flow | $-9,482 | $-8,509 | $-5,882 | $-2,527 | $-7,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 2,916 |
| PPE Investments | -12 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -3,045 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -3,045 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,057 | $N/A | $N/A | $N/A | $2,916 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 250 |
| Debt Issued | N/A | N/A | N/A | N/A | 790 |
| Debt Repayment | N/A | -190 | -125 | -62 | -847 |
| Common Stock Issued | 9,490 | 9,490 | 9,490 | 5,410 | 3,993 |
| Other Financing Activity | 1,463 | -616 | -585 | -229 | -431 |
| Financing Cash Flow | $10,952 | $8,683 | $8,780 | $5,119 | $3,755 |
| Beginning Cash Position | 1,920 | 1,920 | 1,920 | 1,920 | 2,576 |
| End Cash Position | 334 | 2,095 | 4,818 | 4,513 | 1,920 |
| Net Cash Flow | $-1,586 | $175 | $2,898 | $2,593 | $-656 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,482 | -8,509 | -5,882 | -2,527 | -7,327 |
| Capital Expenditure | -12 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -9,494 | -8,509 | -5,882 | -2,527 | -7,327 |